Skip to main content
. 2020 Oct 11;26:e928054-1–e928054-13. doi: 10.12659/MSM.928054

Table 4.

Prognostic analysis on 3-year DFS in patients with colorectal cancer.

Variables Univariate analysis Multivariate analysis
HR (95%CI) P value HR (95%CI) P value
Incisional SSI 0.581 (0.213–1.588) 0.290
Organ/space SSI 1.492 (0.603–3.693) 0.387
Incisional+organ/space SSI 2.794 (1.624–4.806) <0.001 4.000 (1.459–10.964) 0.007
Sex F Ref.
M 1.006 (0.669–1.514) 0.977
Age ≥60 (year) 1.596 (1.073–2.376) 0.021 1.880 (1.207–2.929) 0.005
Tumor location Colon Ref.
Rectum 0.786 (0.524–1.177) 0.242
Tumor size (cm) <5 Ref.
≥5 1.297 (0.869–1.935) 0.203
Tumor differentiation poor Ref. Ref.
high 0.568 (0.332–0.971) 0.039 0.932 (0.506–1.718) 0.823
Lymph node involvement 3.280 (2.141–5.025) <0.001 2.968 (1.818–4.847) <0.001
Depth of tumor T1–T2 Ref. Ref.
T3–T4 4.796 (1.950–11.796) <0.001 3.789 (1.166–12.307) 0.027
Operative approach open Ref. Ref.
Lap 0.553 (0.372–0.823) 0.003 0.693 (0.447–1.074) 0.101
Anastomotic leakage 1.839 (1.076–3.144) 0.026 0.557 (0.178–1.743) 0.315
Adjuvant chemotherapy 0.796 (0.535–1.183) 0.259
Preoperative obstruction 1.277 (0.837–1.948) 0.256
Vascular invasion 1.631 (1.047–2.541) 0.031 0.817 (0.482–1.386) 0.454
Perineural invasion 1.860 (1.219–2.838) 0.004 1.372 (0.858–2.192) 0.186
Blood transfusion 1.493 (0.990–2.252) 0.056
Preoperative CEA (ng/ml) <5 Ref. Ref.
≥5 1.545 (1.037–2.304) 0.033 1.079 (0.684–1.701) 0.774
Preoperative CA125 (ng/ml) <35 Ref.
≥35 2.271 (1.289–4.003) 0.005 1.660 (0.873–3.159) 0.122
Preoperative CA199 (ng/ml) <37 Ref.
≥37 1.733 (1.050–2.861) 0.031 1.088 (0.622–1.901) 0.768

HR – hazard ratio; CI – confidence interval; SSI – surgical site infection; F – Female; M – Male; Lap – laparoscopic.